|
SERF1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.364300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.684010E-02 |
| Normal-vs-Stage2 |
2.422700E-03 |
| Normal-vs-Stage3 |
1.625030E-01 |
| Normal-vs-Stage4 |
3.566200E-01 |
| Stage1-vs-Stage2 |
1.476760E-01 |
| Stage1-vs-Stage3 |
6.511600E-01 |
| Stage1-vs-Stage4 |
7.088600E-01 |
| Stage2-vs-Stage3 |
1.020230E-01 |
| Stage2-vs-Stage4 |
3.148200E-01 |
| Stage3-vs-Stage4 |
9.500400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.963400E-03 |
| Normal-vs-AfricanAmerican |
4.773600E-02 |
| Normal-vs-Asian |
9.449400E-01 |
| Caucasian-vs-AfricanAmerican |
3.061200E-01 |
| Caucasian-vs-Asian |
4.134400E-01 |
| AfricanAmerican-vs-Asian |
5.348400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.189800E-04 |
| Normal-vs-Female |
8.513200E-01 |
| Male-vs-Female |
6.21549999999527E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.351040E-01 |
| Normal-vs-Extreme_Weight |
2.501500E-03 |
| Normal-vs-Obese |
8.943200E-03 |
| Normal-vs-Extreme_Obese |
5.062400E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.068400E-01 |
| Normal_Weight-vs-Obese |
4.651600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.243600E-01 |
| Extreme_Weight-vs-Obese |
7.186800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.159600E-01 |
| Obese-vs-Extreme_Obese |
5.950800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.525600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.033900E-02 |
| Normal-vs-Age(61-80Yrs) |
5.793400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.451810E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.919000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.112400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.688640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.494100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.564040E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.539200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.983720E-03 |
| Normal-VS-Type2 PRCC |
4.615500E-03 |
| Normal-VS-KIRP CIMP |
6.592400E-01 |
| Normal-VS-Unclassified PRCC |
3.994300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.495200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.912180E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.585000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.991160E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.524600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.713400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.040700E-03 |
| Normal-vs-N1 |
3.429200E-01 |
| Normal-vs-N2 |
2.456000E-01 |
| N0-vs-N1 |
1.887630E-01 |
| N0-vs-N2 |
2.299000E-01 |
| N1-vs-N2 |
1.635590E-01 |
|
|
